MONITORING OF FERRITIN LEVELS AFTER BLOOD TRANSFUSIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

被引：0
|
作者：
Rozema, J. [1 ,2 ]
Van Asten, I. [3 ]
Kwant, B. [1 ]
Kibbelaar, R. [4 ]
Veeger, N. [5 ,6 ]
De Wit, H. [3 ]
Van Roon, E. [1 ,2 ]
Hoogendoorn, M. [7 ]
机构：
[1] Univ Groningen, Pharmacotherapy Epidemiol & Econ, Groningen, Netherlands
[2] Med Ctr Leeuwarden, Clin Pharm & Pharmacol, Leeuwarden, Netherlands
[3] Certe Med Diagnost & Advice, Locat Mcl, Leeuwarden, Netherlands
[4] Pathol Friesland, Pathol, Leeuwarden, Netherlands
[5] Med Ctr Leeuwarden, Sci Bur, Leeuwarden, Netherlands
[6] Univ Med Ctr Groningen, Epidemiol, Groningen, Netherlands
[7] Med Ctr Leeuwarden, Internal Med, Leeuwarden, Netherlands
来源：
LEUKEMIA RESEARCH | 2021年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P61
引用
下载
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] Monitoring of Plasma Ferritin Levels after Blood Transfusions in Patients with Myelodysplastic Syndromes
    Rozema, Johanne
    Van Asten, Ivar
    Kwant, Beau
    Kibbelaar, Robby E.
    Veeger, Nic J. G. M.
    De Wit, Harry
    Van Roon, Eric N.
    Hoogendoorn, Mels
    BLOOD, 2021, 138 : 1986 - +
  • [2] Transfusions at home in patients with myelodysplastic syndromes
    Niscola, Pasquale
    Tendas, Andrea
    Giovannini, Marco
    Cupelli, Luca
    Trawinska, Malgorzata Monika
    Palombi, Massimiliano
    Scaramucci, Laura
    Brunetti, Gregorio Antonio
    Perrotti, Alessio
    Neri, Benedetta
    Efficace, Fabio
    Cartoni, Claudio
    de Fabritiis, Paolo
    Mandelli, Franco
    LEUKEMIA RESEARCH, 2012, 36 (06) : 684 - 688
  • [3] Transfusions in myelodysplastic syndromes
    Rose, C.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2017, 24 (03) : 209 - 215
  • [4] Self-perception of symptoms of anemia and fatigue before and after blood transfusions in patients with myelodysplastic syndromes
    Ryblom, Harriet
    Hast, Robert
    Hellstrom-Lindberg, Eva
    Winterling, Jeanette
    Johansson, Eva
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2015, 19 (02) : 99 - 106
  • [5] Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes
    Jabbour, Elias
    Kantarjian, Hagop M.
    Koller, Charles
    Taher, Ali
    CANCER, 2008, 112 (05) : 1089 - 1095
  • [6] ERYTHROCYTE FERRITIN CONCENTRATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    PETERS, SW
    MAY, SJ
    JACOBS, A
    JOURNAL OF CLINICAL PATHOLOGY, 1985, 38 (01) : 113 - 114
  • [7] SERUM FERRITIN LEVELS IN PRETERM INFANTS AFTER MULTIPLE BLOOD-TRANSFUSIONS
    ARAD, I
    KONIJN, AM
    LINDER, N
    GOLDSTEIN, M
    KAUFMANN, NA
    AMERICAN JOURNAL OF PERINATOLOGY, 1988, 5 (01) : 40 - 43
  • [8] STUDY OF THE BURDEN OF BLOOD TRANSFUSIONS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES WHO RECEIVE REGULAR TRANSFUSIONS
    Jeanblanc, G.
    Roset, Q.
    Schmidt, A.
    Jouaneton, B.
    Jolivel, R.
    VALUE IN HEALTH, 2020, 23 : S448 - S448
  • [9] Outpatient transfusions for myelodysplastic syndromes
    Wood, Erica M.
    McQpilten, Zoe K.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 167 - 174
  • [10] Patient and physician perceptions about blood transfusions in the myelodysplastic syndromes
    King, David
    Schmidt, Rodney
    Lesser, Matthew
    Houk, Alice
    Salkeld, Ellen
    Cogle, Christopher R.
    LEUKEMIA RESEARCH, 2020, 96
12345